M, S., X, J., Y, X., T, Z., R, T., L, F., & X, L. (2022). Using Glycated Albumin and Stimulated C-Peptide to Define Partial Remission in Type 1 Diabetes. Frontiers in endocrinology, 13, 938059. https://doi.org/10.3389/fendo.2022.938059
Chicago Style (17th ed.) CitationM, Shi, Ji X, Xie Y, Zhong T, Tang R, Fan L, and Li X. "Using Glycated Albumin and Stimulated C-Peptide to Define Partial Remission in Type 1 Diabetes." Frontiers in Endocrinology 13 (2022): 938059. https://doi.org/10.3389/fendo.2022.938059.
MLA (9th ed.) CitationM, Shi, et al. "Using Glycated Albumin and Stimulated C-Peptide to Define Partial Remission in Type 1 Diabetes." Frontiers in Endocrinology, vol. 13, 2022, p. 938059, https://doi.org/10.3389/fendo.2022.938059.
Warning: These citations may not always be 100% accurate.